Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration | Zendy

Marissa B. Wilck | Zendy; Michael S. Seaman | Zendy; Lindsey R. Baden | Zendy; Stephen R. Walsh | Zendy; Lauren E. Grandpre | Zendy; Colleen Devoy | Zendy; Ayush Giri | Zendy; Jane A. Kleinjan | Zendy; Lizanne C. Noble | Zendy; Kristen E. Stevenson | Zendy; Haesook T. Kim | Zendy; Raphael Dolin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration

Author(s) -

Marissa B. Wilck,

Michael S. Seaman,

Lindsey R. Baden,

Stephen R. Walsh,

Lauren E. Grandpre,

Colleen Devoy,

Ayush Giri,

Jane A. Kleinjan,

Lizanne C. Noble,

Kristen E. Stevenson,

Haesook T. Kim,

Raphael Dolin

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/651561

Subject(s) - immunogenicity , vaccinia , virology , modified vaccinia ankara , administration (probate law) , medicine , route of administration , smallpox vaccine , pharmacology , immunology , biology , immune system , recombinant dna , biochemistry , gene , political science , law

We conducted a clinical trial of the safety and immunogenicity of modified vaccinia Ankara (MVA) to examine the effects of dose and route of administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research